RNA Biology
One of the areas that falls within the Medical Schools overall strategy in the area of personalised medicine is RNA Biology. The importance and impact of RNA Biology is demonstrated by the new Covid-19 RNA vaccine technology recently used by Pfizer and Moderna.
Research in this area seeks to understand the way the RNA molecules are regulated in the cell to control important cellular processes such as cell proliferation and migration. This underpinning research is very relevant to the understanding of human diseases such as cancers, inflammation, infection, neurodegeneration and response to stress. In particular, small RNA molecules, such as microRNAs, which are present in body fluids have potential as prognostic and diagnostic biomarkers therefore will have impact on devising therapies for particular diseases. Those working in the area of RNA biology have close links with research groups working in Life Sciences, University of Sussex; particularly in Biochemistry and Biomedicine and Neuroscience. They are part of the very active University of Sussex RNA Research Group.
Our researchers
Prof Sarah Newbury
Prof Simon Waddell
Prof Sandra Sacre
Dr Manuela Mengozzi
Dr Chris Jones
Dr John Jones